ADMINISTERING
MEDICATIONS: 2025 RELEASE
• AUTHOR(S)DONNA
GAUWITZ
TEST BANK
1
Reference
Ch. 1 — Utilizing eMAR Technology
Stem
A nurse preparing to administer morning medications uses the
unit eMAR. The eMAR shows a scheduled dose of lisinopril 10
mg due now; the patient’s allergy band lists “angioedema with
ACE inhibitors.” The eMAR does not flag the allergy. What
should the nurse do first?
,A. Administer the lisinopril because the order appears valid on
eMAR.
B. Hold the medication and contact the prescriber to clarify the
order.
C. Remove the allergy from the chart to prevent future eMAR
alerts.
D. Give the medication and document the allergy discrepancy in
the chart afterwards.
Correct Answer
B
Rationales
Correct (B): The nurse must prioritize patient safety and
reconcile apparent conflicts between medication orders and
documented allergies before administration. Contacting the
prescriber protects the patient from a potentially life-
threatening reaction and follows safe eMAR use and error-
prevention standards.
A: Unsafe — relying solely on eMAR without reconciling an
allergy risks patient harm. eMAR is a tool, not a substitute for
clinical judgment.
C: Unsafe and illegal — altering allergy data to avoid alerts
endangers the patient and violates documentation standards.
D: Unsafe — administering despite a known allergy is negligent;
documentation after harm does not justify the action.
,Teaching Point
Always reconcile eMAR orders with allergies; clarify
discrepancies before administration.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
2
Reference
Ch. 1 — Drug Names / Brand-Name Drugs versus Generic-Name
Drugs
Stem
A patient refuses to take “metoprolol” because he says he takes
“Lopressor” at home and believes they are different drugs. The
eMAR lists metoprolol tartrate. How should the nurse respond?
A. Tell the patient they are different and obtain a physician’s
order to stop the medication.
B. Explain that metoprolol and Lopressor are the same active
drug and confirm home dosing information.
C. Substitute another beta-blocker without consulting the
prescriber.
D. Document the refusal and leave the unit.
Correct Answer
B
, Rationales
Correct (B): The nurse must educate using accurate drug-name
information: Lopressor is a brand name for metoprolol;
confirming home dosing and reconciling with the eMAR
prevents duplication or omissions and supports adherence.
A: Incorrect — they are the same active ingredient; stopping
therapy without reason risks patient harm.
C: Unsafe — substitution requires prescriber authorization and
knowledge of indication and formulation.
D: Incomplete and unprofessional — refusal requires
assessment, education, and documentation, not abandoning
the patient.
Teaching Point
Clarify brand versus generic names and reconcile with patient’s
home regimen before acting.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
3
Reference
Ch. 1 — Drug References; Coping with Changing Information
Stem
A nurse encounters a new oral antibiotic order for an older
adult. Recent literature (published yesterday) suggests dosage
reduction in renal impairment, and the patient’s latest labs
MEDICATIONS: 2025 RELEASE
• AUTHOR(S)DONNA
GAUWITZ
TEST BANK
1
Reference
Ch. 1 — Utilizing eMAR Technology
Stem
A nurse preparing to administer morning medications uses the
unit eMAR. The eMAR shows a scheduled dose of lisinopril 10
mg due now; the patient’s allergy band lists “angioedema with
ACE inhibitors.” The eMAR does not flag the allergy. What
should the nurse do first?
,A. Administer the lisinopril because the order appears valid on
eMAR.
B. Hold the medication and contact the prescriber to clarify the
order.
C. Remove the allergy from the chart to prevent future eMAR
alerts.
D. Give the medication and document the allergy discrepancy in
the chart afterwards.
Correct Answer
B
Rationales
Correct (B): The nurse must prioritize patient safety and
reconcile apparent conflicts between medication orders and
documented allergies before administration. Contacting the
prescriber protects the patient from a potentially life-
threatening reaction and follows safe eMAR use and error-
prevention standards.
A: Unsafe — relying solely on eMAR without reconciling an
allergy risks patient harm. eMAR is a tool, not a substitute for
clinical judgment.
C: Unsafe and illegal — altering allergy data to avoid alerts
endangers the patient and violates documentation standards.
D: Unsafe — administering despite a known allergy is negligent;
documentation after harm does not justify the action.
,Teaching Point
Always reconcile eMAR orders with allergies; clarify
discrepancies before administration.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
2
Reference
Ch. 1 — Drug Names / Brand-Name Drugs versus Generic-Name
Drugs
Stem
A patient refuses to take “metoprolol” because he says he takes
“Lopressor” at home and believes they are different drugs. The
eMAR lists metoprolol tartrate. How should the nurse respond?
A. Tell the patient they are different and obtain a physician’s
order to stop the medication.
B. Explain that metoprolol and Lopressor are the same active
drug and confirm home dosing information.
C. Substitute another beta-blocker without consulting the
prescriber.
D. Document the refusal and leave the unit.
Correct Answer
B
, Rationales
Correct (B): The nurse must educate using accurate drug-name
information: Lopressor is a brand name for metoprolol;
confirming home dosing and reconciling with the eMAR
prevents duplication or omissions and supports adherence.
A: Incorrect — they are the same active ingredient; stopping
therapy without reason risks patient harm.
C: Unsafe — substitution requires prescriber authorization and
knowledge of indication and formulation.
D: Incomplete and unprofessional — refusal requires
assessment, education, and documentation, not abandoning
the patient.
Teaching Point
Clarify brand versus generic names and reconcile with patient’s
home regimen before acting.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
3
Reference
Ch. 1 — Drug References; Coping with Changing Information
Stem
A nurse encounters a new oral antibiotic order for an older
adult. Recent literature (published yesterday) suggests dosage
reduction in renal impairment, and the patient’s latest labs
